BACKGROUND: Transplanting pancreatic islets is of significant interest for type 1 diabetes mellitus. After intraportal injection of islets, inferior engraftment and eventual loss of transplanted islets constitute major limitations. Therefore, alternative approaches will be helpful. Here, we evaluated in animals whether an isolated venous sac would support survival of transplanted islets, along with correction of hyperglycemia. METHODS: Pancreatic islets isolated from adult Lewis rats were transplanted either into an isolated venous sac made from lumbar vein or into the portal vein of syngeneic rats. The integrity and vascular organization of the venous sac was determined by studies of the local microcirculation. The engraftment, survival, and function of transplanted islets were analyzed by histology, including endocrine function in situ and by glycemic control in rats with streptozotocin-induced diabetes. RESULTS: Transplanted islets showed normal morphology with insulin expression in isolated venous sac during the long term. Transplanted islets received blood supply from vasa vasorum and had access to drainage through venous tributaries in the venous sac. This resulted in restoration of euglycemia in diabetic rats. Removal of islet graft-bearing venous sac in diabetic rats led to recurrence of hyperglycemia. By contrast, euglycemia was not restored in rats treated by intraportal transplantation of islets. CONCLUSIONS: We demonstrated that pancreatic islets successfully engrafted and functioned in the isolated venous sac with ability to restore euglycemia in diabetic rats. Therefore, the isolated venous sac offers a new site for transplantation of pancreatic islets. This would be clinically beneficial as an alternative to intrahepatic islet transplantation.
BACKGROUND: Transplanting pancreatic islets is of significant interest for type 1 diabetes mellitus. After intraportal injection of islets, inferior engraftment and eventual loss of transplanted islets constitute major limitations. Therefore, alternative approaches will be helpful. Here, we evaluated in animals whether an isolated venous sac would support survival of transplanted islets, along with correction of hyperglycemia. METHODS:Pancreatic islets isolated from adult Lewis rats were transplanted either into an isolated venous sac made from lumbar vein or into the portal vein of syngeneic rats. The integrity and vascular organization of the venous sac was determined by studies of the local microcirculation. The engraftment, survival, and function of transplanted islets were analyzed by histology, including endocrine function in situ and by glycemic control in rats with streptozotocin-induced diabetes. RESULTS: Transplanted islets showed normal morphology with insulin expression in isolated venous sac during the long term. Transplanted islets received blood supply from vasa vasorum and had access to drainage through venous tributaries in the venous sac. This resulted in restoration of euglycemia in diabeticrats. Removal of islet graft-bearing venous sac in diabeticrats led to recurrence of hyperglycemia. By contrast, euglycemia was not restored in rats treated by intraportal transplantation of islets. CONCLUSIONS: We demonstrated that pancreatic islets successfully engrafted and functioned in the isolated venous sac with ability to restore euglycemia in diabeticrats. Therefore, the isolated venous sac offers a new site for transplantation of pancreatic islets. This would be clinically beneficial as an alternative to intrahepatic islet transplantation.
Authors: T Linn; K Schneider; H P Hammes; K T Preissner; H Brandhorst; E Morgenstern; F Kiefer; R G Bretzel Journal: FASEB J Date: 2003-03-28 Impact factor: 5.191
Authors: M D Bellin; F B Barton; A Heitman; J V Harmon; R Kandaswamy; A N Balamurugan; D E R Sutherland; R Alejandro; B J Hering Journal: Am J Transplant Date: 2012-04-11 Impact factor: 8.086
Authors: L Moberg; H Johansson; A Lukinius; C Berne; A Foss; R Källen; Ø Østraat; K Salmela; A Tibell; G Tufveson; G Elgue; K Nilsson Ekdahl; O Korsgren; B Nilsson Journal: Lancet Date: 2002 Dec 21-28 Impact factor: 79.321
Authors: Stephen T Bartlett; James F Markmann; Paul Johnson; Olle Korsgren; Bernhard J Hering; David Scharp; Thomas W H Kay; Jonathan Bromberg; Jon S Odorico; Gordon C Weir; Nancy Bridges; Raja Kandaswamy; Peter Stock; Peter Friend; Mitsukazu Gotoh; David K C Cooper; Chung-Gyu Park; Phillip OʼConnell; Cherie Stabler; Shinichi Matsumoto; Barbara Ludwig; Pratik Choudhary; Boris Kovatchev; Michael R Rickels; Megan Sykes; Kathryn Wood; Kristy Kraemer; Albert Hwa; Edward Stanley; Camillo Ricordi; Mark Zimmerman; Julia Greenstein; Eduard Montanya; Timo Otonkoski Journal: Transplantation Date: 2016-02 Impact factor: 4.939
Authors: Zurab Kakabadze; Lia Karalashvili; David Chakhunashvili; Necat Havlioglu; Merab Janelidze; Ann Kakabadze; Yogeshwar Sharma; Sanjeev Gupta Journal: Mater Sci Eng C Mater Biol Appl Date: 2018-12-10 Impact factor: 7.328
Authors: Undine Schubert; Janine Schmid; Susann Lehmann; Xian Y Zhang; Henning Morawietz; Norman L Block; Waldemar Kanczkowski; Andrew V Schally; Stefan R Bornstein; Barbara Ludwig Journal: Proc Natl Acad Sci U S A Date: 2013-01-23 Impact factor: 11.205
Authors: Charles-Henri Wassmer; Fanny Lebreton; Kevin Bellofatto; Lisa Perez; David Cottet-Dumoulin; Axel Andres; Domenico Bosco; Thierry Berney; Véronique Othenin-Girard; Begoña Martinez De Tejada; Marie Cohen; Christina Olgasi; Antonia Follenzi; Ekaterine Berishvili Journal: Transpl Int Date: 2022-01-21 Impact factor: 3.842
Authors: Andrew R Pepper; Rena Pawlick; Boris Gala-Lopez; Amanda MacGillivary; Delfina M Mazzuca; David J G White; Philip M Toleikis; A M James Shapiro Journal: Transplantation Date: 2015-11 Impact factor: 4.939